Agios to Present at March Investor Conferences

Rhea-AI Summary

Agios Pharmaceuticals (NASDAQ:AGIO) announced its participation in two upcoming virtual investor conferences in March 2021. The first is the Cowen 41^st Annual Virtual Healthcare Conference on March 1, 2021, at 11:40 a.m. ET, followed by the Oppenheimer 31^st Annual Virtual Healthcare Conference on March 17, 2021, at 9:20 a.m. ET. Live webcasts of the presentations will be available on Agios's website, with replays archived for at least two weeks post-event. The company focuses on developing treatments for cancer and genetic diseases through cellular metabolism research.

CAMBRIDGE, Mass., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and genetically defined diseases, today announced that the company is scheduled to present at the following March investor conferences:

• Cowen 41^st Annual Virtual Healthcare Conference on Monday, March 1, 2021 at 11:40 a.m. ET; and
• Oppenheimer 31^st Annual Virtual Healthcare Conference on Wednesday, March 17, 2021 at 9:20 a.m. ET.

Live webcasts of the presentations can be accessed under "Events & Presentations" in the Investors section of the company's website at www.agios.com. Replays of the webcasts will be archived on the Agios website for at least two weeks following each presentation.

About Agios
Agios is focused on discovering and developing novel investigational medicines to treat malignant hematology, solid tumors and genetically defined diseases through scientific leadership in the field of cellular metabolism. In addition to an active research and discovery pipeline across these three therapeutic areas, Agios has two approved oncology precision medicines and multiple first-in-class investigational therapies in clinical and/or preclinical development. For more information, please visit the company's website at www.agios.com.

Contacts

Investors & Media:
Holly Manning, 617-844-6630
Director, Investor Relations
Holly.Manning@agios.com

FAQ

When is Agios Pharmaceuticals presenting at the Cowen conference?

Agios Pharmaceuticals will present at the Cowen 41^st Annual Virtual Healthcare Conference on March 1, 2021, at 11:40 a.m. ET.

What date is Agios Pharmaceuticals scheduled to present at the Oppenheimer conference?

Agios Pharmaceuticals is set to present at the Oppenheimer 31^st Annual Virtual Healthcare Conference on March 17, 2021, at 9:20 a.m. ET.

Where can I watch the Agios Pharmaceuticals conference presentations?

Live webcasts of the Agios Pharmaceuticals presentations can be accessed on their website under 'Events & Presentations.'

How long will the Agios Pharmaceuticals conference replays be available?

Replays of Agios Pharmaceuticals' conference webcasts will be archived on their website for at least two weeks following each presentation.

What is the focus of Agios Pharmaceuticals' research?

Agios Pharmaceuticals focuses on discovering and developing investigational medicines for cancer and genetically defined diseases through cellular metabolism.